KEITH BROWN, President and CEO of TissueGen

Chris Phipps interviews Keith Brown, President and CEO of TissueGen, located in Dallas near the UTSW Medical Center. TissueGen is developing the next generation of biodegradable drug eluting stents. Keith Brown was named CEO and President of TissueGen in Janurary 2005, and before that he spent 15 years in venture backed biotech companies. One of the more notable companies was GeneScreen, where he was founder and President and led them to $15M in annual sales at the time of their acquisition by Orchid Biosciences. Keith then helped Orchid through a successful IPO. Keith obtained his MBA with distinction from the Harvard School of Business.